The Lombardi Comprehensive Cancer Center's (LCCC) Senior Leadership includes Louis Weiner, MD, Director; Michael Atkins, MD, Deputy Director; six Associate Directors: Anton Wellstein, MD, PhD (Basic & Translational Science Research); Giuseppe Giaccone MD, PhD (Clinical Research); Jeanne Mandelblatt, MD, MPH (Population Science Research); Lucile Adams-Campbell, PhD (Minority Health & Health Disparities Research); Stephen Byers, PhD (Shared Resources); and Michael Vander Hoek, MHSA (Administration); and MedStar Georgetown Cancer Network Representative (Sandra Swain, MD). These individuals constitute the LCCC Executive Committee (EC). As Director, Weiner is responsible for the overall operation and development of the Cancer Center, including its research, educational, and clinical missions. As such he has oversight of the four Research Programs, nine Shared Resources, and all LCCC activities. Atkins, an expert on clinical and translational research, joined as Deputy Director on April 1, 2012. He assists the Director in coordinating Cancer Center activities with specific attention to advancing transdisciplinary research initiatives and integrating clinical research and educational activities within the Cancer Center. EC members guide LCCC's activities with an emphasis on fostering transdisciplinary and translational interactions to achieve the Center's mission. Specifically, the EC oversees Center-wide strategic, operational and educational initiatives; prioritizes overarching goals of the Center related to its mission and comprehensive cancer center status; sets and reviews metrics for each of the respective areas overseen by EC members; prioritizes and oversees developmental funding, resource allocation, and new faculty recruitment; identifies and evaluates new themes and initiatives; reviews opportunities for conducting novel clinical and population research within the MedStar Georgetown Cancer Network to address cancer issues in our local catchment area and nationally; and approves Center membership and membership criteria. Overall, the leadership team brings scientific, clinical, and administrative expertise to all areas of the Center's activities and is ideally structured to help LCCC fulfill its mission.

Public Health Relevance

Lombardi's senior leadership oversees Center-wide strategic and operational initiatives to guide LCCC's activities with an emphasis on fostering transdisciplinary and translational interactions to achieve the Center's mission.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA051008-25S1
Application #
9692527
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Ptak, Krzysztof
Project Start
Project End
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
25
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Laiakis, Evagelia C; Mak, Tytus D; Strawn, Steven J et al. (2018) Global metabolomic responses in urine from atm deficient mice in response to LD50/30 gamma irradiation doses. Environ Mol Mutagen 59:576-585
O'Neill, Suzanne C; Taylor, Kathryn L; Clapp, Jonathan et al. (2018) Multilevel Influences on Patient-Oncologist Communication about Genomic Test Results: Oncologist Perspectives. J Health Commun 23:679-686
Kim, Sang-Soo; Harford, Joe B; Moghe, Manish et al. (2018) Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide. Nucleic Acids Res 46:1424-1440
Wallington, Sherrie; Oppong, Bridget; Dash, Chiranjeev et al. (2018) A Community-Based Outreach Navigator Approach to Establishing Partnerships for a Safety Net Mammography Screening Center. J Cancer Educ 33:782-787
Wärri, Anni; Cook, Katherine L; Hu, Rong et al. (2018) Autophagy and unfolded protein response (UPR) regulate mammary gland involution by restraining apoptosis-driven irreversible changes. Cell Death Discov 4:40
Pohlmann, Paula R; Isaacs, Claudine (2018) Extended Adjuvant Endocrine Therapy for Postmenopausal Women: Treating Many to Benefit a Few. J Natl Cancer Inst 110:
Fu, Ying; Silverstein, Shana; McCutcheon, Justine N et al. (2018) An endogenous DNA adduct as a prognostic biomarker for hepatocarcinogenesis and its prevention by Theaphenon E in mice. Hepatology 67:159-170
Stires, Hillary; Heckler, Mary M; Fu, Xiaoyong et al. (2018) Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities. Mol Cell Endocrinol 471:105-117
Xiao, David; Zheng, Chaoyi; Jindal, Manila et al. (2018) Medicaid Expansion and Disparity Reduction in Surgical Cancer Care at High-Quality Hospitals. J Am Coll Surg 226:22-29
Kozlik, Petr; Goldman, Radoslav; Sanda, Miloslav (2018) Hydrophilic interaction liquid chromatography in the separation of glycopeptides and their isomers. Anal Bioanal Chem 410:5001-5008

Showing the most recent 10 out of 1120 publications